Jadenu 90 mg (Deferasirox TABLET) 90 MG

JADENU 90 MG tablets contain deferasirox, a medication used to manage iron overload. This oral tablet is designed for convenient administration and is manufactured by Novartis Pharmaceuticals Canada Inc.

Strength

90 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JADENU 90 MG tablets are primarily used to manage iron overload in certain medical conditions. Deferasirox, the active ingredient, helps to reduce excess iron in the body. This medication is often prescribed for individuals who require regular iron removal to maintain healthy levels.

Side Effects

Common effects of JADENU 90 MG tablets may include gastrointestinal discomfort, skin rash, and changes in liver function. Some users may also experience fatigue or dizziness. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

JADENU 90 MG tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Always follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not share this medication with others.

Avoid Interactions

JADENU 90 MG tablets may interact with certain medications, including those metabolized by the liver. Alcohol and other substances that affect liver function should be avoided. Inform your healthcare provider about all medications you are taking to prevent potential interactions.

Frequently Asked Questions

JADENU 90 MG tablets are used to manage iron overload in certain medical conditions. The active ingredient, deferasirox, helps to reduce excess iron in the body.

JADENU 90 MG tablets are taken orally, typically once daily. Follow the administration instructions provided by your healthcare provider.

Common side effects may include gastrointestinal discomfort, skin rash, and changes in liver function. Some users may also experience fatigue or dizziness.

It is generally advised to avoid alcohol while taking JADENU 90 MG tablets, as it may affect liver function and interact with the medication.

Store JADENU 90 MG tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.